Tyrosine Kinase Inhibitors Market Size, Trends, Share, Growth, and Opportunity Forecast, 2023 - 2030 Global Industry Analysis By Type (EPFGR, ALK, and Others), By Indication (Chronic Myeloid Leukemia (CML), Acute Lymphoblastic Leukemia (ALL), Gastrointestinal Stromal Tumors (GIST), Non-Small Cell Lung Cancer (NSCLC), Renal Cell Carcinoma (RCC), and Others), By End Use (Hospitals and Clinics, Ambulatory Surgical Centers, and Institutions), and By Geography (North America, Europe, Asia Pacific, South America, and Middle East & Africa)
Region: Global
Published: January 2024
Report Code: CGNPHR295
Pages: 164